Mesothelin is elevated in the serum of 76% ovarian cancer patients (Diamandis et al, 2000) and kallikrein 10 is elevated in 56% of ovarian cancer patients (Luo et al, 2001). This evidence concerns the gene KLK10 and ovarian carcinoma.